Cedar Hill Associates’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q4 | $3.35M | Sell |
34,770
-21,667
| -38% | -$2.09M | 1.28% | 28 |
|
2018
Q3 | $6.88M | Sell |
56,437
-5,729
| -9% | -$699K | 1.55% | 23 |
|
2018
Q2 | $6.83M | Sell |
62,166
-5,645
| -8% | -$620K | 1.42% | 25 |
|
2018
Q1 | $7.24M | Sell |
67,811
-7,402
| -10% | -$790K | 1.44% | 28 |
|
2017
Q4 | $8.03M | Sell |
75,213
-54,663
| -42% | -$5.84M | 1.4% | 28 |
|
2017
Q3 | $14.4M | Sell |
129,876
-891
| -0.7% | -$99.1K | 2.49% | 5 |
|
2017
Q2 | $13.5M | Sell |
130,767
-4,080
| -3% | -$422K | 2.81% | 9 |
|
2017
Q1 | $13.2M | Sell |
134,847
-52,089
| -28% | -$5.09M | 2.75% | 12 |
|
2016
Q4 | $16.5M | Sell |
186,936
-1,845
| -1% | -$163K | 2.78% | 12 |
|
2016
Q3 | $18.2M | Buy |
188,781
+15,609
| +9% | +$1.51M | 2.98% | 7 |
|
2016
Q2 | $14.9M | Buy |
173,172
+5,565
| +3% | +$477K | 2.55% | 16 |
|
2016
Q1 | $14.6M | Buy |
167,607
+10,980
| +7% | +$955K | 2.53% | 17 |
|
2015
Q4 | $17.7M | Buy |
156,627
+59,163
| +61% | +$6.67M | 3.11% | 6 |
|
2015
Q3 | $9.86M | Sell |
97,464
-58,464
| -37% | -$5.91M | 1.75% | 28 |
|
2015
Q2 | $19.2M | Sell |
155,928
-1,422
| -0.9% | -$175K | 3.02% | 6 |
|
2015
Q1 | $18M | Buy |
157,350
+56,415
| +56% | +$6.46M | 2.86% | 6 |
|
2014
Q4 | $10.2M | Buy |
+100,935
| New | +$10.2M | 1.61% | 28 |
|